Antoni Ribas, MD, PhD: For certain cancers where we know it can only work in a specific situation that has a specific marker, having a companion diagnostic makes a lot of sense. You want to select ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Add Yahoo as a preferred source to see more of our stories on Google. MiraDx's Prostox Standard test aims to identify localised prostate cancer patients who may experience long-term California-based ...

Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast CTX, a new predictive capability within its Ataraxis Breast ...

New University of Utah research reveals the potential of medication informatics and DNA drug-sensitivity testing to reduce overall healthcare resource use and costs in elderly patients treated with ...